Evidence map›Paper›PMID 35193700›Full record

ReviewLaboratory animal research2022

The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans.

Ricardo Lacava Bailone, Hirla Costa Silva Fukushima, Luis Kluwe de Aguiar, Ricardo Carneiro Borra

Open access · diamondAbstract readReview
In one paragraph

Review in Laboratory animal research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Exploring Cannabinoid Effects Using Zebrafish (International journal of molecular sciences · 2025
    Review
  2. Article
  3. Changes of CB1 Receptor Expression in Tissues of Cocaine-Exposed Eels.Animals : an open access journal from MDPI · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ricardo Lacava BailoneDepartment of Genetic and Evolution, Federal University of São Carlos, Washington Luiz Road, km 230, São Carlos City, São Paulo County, 13565-905, Brazil. ricardo.bailone@agricultura.gov.br.ORCID http://orcid.org/0000-0003-1935-6624
Hirla Costa Silva FukushimaCentre of Biological and Health Sciences, Federal University of Sao Carlos, São Carlos, Brazil.
Luis Kluwe de AguiarDepartment of Food, Land and Agribusiness Management, Harper Adams University, Newport, England.
Ricardo Carneiro BorraDepartment of Genetic and Evolution, Federal University of São Carlos, Washington Luiz Road, km 230, São Carlos City, São Paulo County, 13565-905, Brazil.
Universidade Federal de São Carlos · BRHarper Adams University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zebrafish is considered an unprecedented animal model in drug discovery. A review of the literature presents highlights and elucidates the biological effects of chemical components found in Cannabis sativa. Particular attention is paid to endocannabinoid system (eCB) and its main receptors (CB1 and CB2). The zebrafish model is a promising one for the study of cannabinoids because of the many similarities to the human system. Despite the recent advances on the eCB system, there is still the need to elucidate some of the interactions and, thus, the zebrafish model can be used for that purpose as it respects the 3Rs concept and reduced time and costs. In view of the relevance of cannabinoids in the treatment and prevention of diseases, as well as the importance of the zebrafish animal model in elucidating the biological effects of new drugs, the aim of this study was to bring to light information on the use of the zebrafish animal model in testing C. sativa-based medicines.

Indexed as

3R∆9-tetrahydrocannabinolAnimal model researchCannabidiolCB1CB2

Identifiers

PMID35193700
PMCPMC8862295
OpenAlexW4213374525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.